7-Tesla ultra-high-field MRI facilitates more accurate diagnosis of breasts cancer, says study Taking component in a recent study, scientists at the MedUni Vienna have demonstrated for the very first time worldwide that 7-Tesla ultra-high-line of business magnetic resonance imaging can be used for clinical applications in patients with breast tumours. The scientists' work has been released in the highly respected journal ‘European Radiology’. In previous studies involving 7-Tesla MRI, the exploration of medical application offers previously been limited to just one breast because of the limited coil technology available.Second, stroke assessments were limited, since neurologic assessments were not mandated, modified Rankin ratings were not used to determine scientific disability, and documentation of atrial fibrillation anticoagulation and episodes regimens had not been complete. Third, the small number of sufferers in whom the transapical strategy was used and the variations in baseline features make a evaluation of the transfemoral and transapical subgroups unreliable. Finally, this research represented the initial experience with TAVR at most of the sites, by using a first-generation device.